14.82
-0.05 (-0.34%)
Previous Close | 14.87 |
Open | 14.81 |
Volume | 199,531 |
Avg. Volume (3M) | 423,671 |
Market Cap | 2,119,912,064 |
Price / Earnings (TTM) | 8.82 |
Price / Earnings (Forward) | 7.27 |
Price / Sales | 0.320 |
Price / Book | 1.66 |
52 Weeks Range | |
Earnings Date | 6 May 2025 |
Profit Margin | 3.73% |
Operating Margin (TTM) | 4.48% |
Diluted EPS (TTM) | 1.68 |
Quarterly Revenue Growth (YOY) | 4.00% |
Quarterly Earnings Growth (YOY) | 53.00% |
Total Debt/Equity (MRQ) | 145.79% |
Current Ratio (MRQ) | 2.12 |
Operating Cash Flow (TTM) | 304.93 M |
Levered Free Cash Flow (TTM) | 41.04 M |
Return on Assets (TTM) | 5.22% |
Return on Equity (TTM) | 23.35% |
Market Trend
Short Term | Medium Term | ||
Industry | Medical Care Facilities (US) | Mixed | Mixed |
Medical Care Facilities (Global) | Mixed | Mixed | |
Stock | Ardent Health Partners, Inc. | Bearish | - |
AIStockmoo Score
Analyst Consensus | 2.0 |
Insider Activity | NA |
Price Volatility | -1.0 |
Technical Moving Averages | 0.0 |
Technical Oscillators | -4.0 |
Average | -0.75 |
Ardent Health Partners Inc is an operator of hospitals and a provider of healthcare services in the United States. It provide both general and specialty services, including internal medicine, general surgery, cardiology, oncology, orthopedics, women’s services, neurology, urology, and emergency services, within inpatient and ambulatory care settings. The company has one reportable segment: healthcare services that provides healthcare services primarily through its ownership and operation of hospitals, certain of which provide related healthcare services through physician practices, outpatient centers, and post-acute facilities. Ardent has 30 acute care hospitals, more than 200 sites of care that operates across six states: Texas, Oklahoma, New Mexico, New Jersey, Idaho, and Kansas. |
|
Sector | Healthcare |
Industry | Medical Care Facilities |
Investment Style | Small Core |
% Held by Insiders | 23.14% |
% Held by Institutions | 73.26% |
Ownership
Name | Date | Shares Held |
---|---|---|
Ventas, Inc. | 31 Dec 2024 | 9,342,501 |
52 Weeks Range | ||
Price Target Range | ||
High | 21.00 (Stephens & Co., 41.70%) | Buy |
21.00 (RBC Capital, 41.70%) | Buy | |
Median | 19.50 (31.58%) | |
Low | 18.00 (Guggenheim, 21.46%) | Buy |
18.00 (Mizuho, 21.46%) | Buy | |
Average | 19.50 (31.58%) | |
Total | 4 Buy | |
Avg. Price @ Call | 14.39 |
Firm | Date | Target Price | Call | Price @ Call |
---|---|---|---|---|
Stephens & Co. | 20 May 2025 | 21.00 (41.70%) | Buy | 15.13 |
01 Apr 2025 | 22.00 (48.45%) | Buy | 12.97 | |
RBC Capital | 15 May 2025 | 21.00 (41.70%) | Buy | 15.23 |
Guggenheim | 09 May 2025 | 18.00 (21.46%) | Buy | 14.52 |
09 Apr 2025 | 16.00 (7.96%) | Buy | 12.67 | |
Mizuho | 09 Apr 2025 | 18.00 (21.46%) | Buy | 12.67 |
No data within this time range.
Date | Type | Details |
---|---|---|
10 Jun 2025 | Announcement | Sidoti Events, LLC's Virtual June Small-Cap Conference |
19 May 2025 | Announcement | Ardent Health Appoints Chief Development Officer to Lead Strategic Growth |
06 May 2025 | Announcement | Ardent Health Reports First Quarter 2025 Results |
05 May 2025 | Announcement | Ardent Health to Participate in May Investor Conferences |
01 May 2025 | Announcement | Seven Ardent Health Facilities Earn “A” Hospital Safety Grade from The Leapfrog Group |
22 Apr 2025 | Announcement | Ardent Health Announces First Quarter 2025 Results Conference Call and Webcast Date |
03 Apr 2025 | Announcement | Ardent Health Appoints Robert DeMichiei to Board of Directors |
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
Realized Profit | - |
Unrealized Profit | - |
Dividend Received 2025 | - |
Total Profit | - |
Avg. Return | - |
Quantity (Buy) | - |
Avg. Price (Buy) | - |
Quantity (Sold) | - |
Avg. Price (Sold) | - |